Boston Scientific receives FDA approval for stents
Boston Scientific Corp has received approval from the FDA to market its new WallFlex Biliary RX covered stents. The stents are designed to treat clogged bile ducts in cancer patients. The liver excretes bile, which the body uses to help digest food. The WallFlex Biliary RX uncovered stent was cleared by the FDA in 2006. The new covered version of the stents was also approved by European regulators.
-
Boston receives FDA approval for Taxus Liberte
Drug-coated stents could boost death rate in heart attack patients
Boston Scientific Announces European Approval and Launch of Platinum Chromium PROMUS(R) Element(TM) Stent System
Boston Scientific receives CE Marking for ALTRUA pacemakers
Medtronic Integrity Coronary Stent Gets FDA Approval
